GenOMICC - The Genetics of Mortality in Critical Care

 Summary

This aim of this study is to

• identify genetic variants within patients which are associated with susceptibility to and mortality from life-threatening infection
• Prioritise therapeutics targets which modulate the patient’s response to the infection

A single DNA sample will be collected from patients with

• Susceptibility to severe infections with Covid-19
• Susceptibility to death following onset of severe illness with Covid-19
• Susceptibility to death from quantifiable sterile injury

DNA will also be obtained from survivors of Covid-19, combined with other DNA resources and then a small cohort of those who are most susceptible will be followed for repeat samples.

This study is complimentary to the ISARIC/WHO study.

Priority

This is a study which is considered a national priority.

Treatment

As an observational study, treatment will be standard care.

Who can participate?

1. Anyone who is considered susceptible to Covid-19
2. Anyone with Covid-19 diagnosis and severe symptoms